$ALIM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALIMERA SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALIMERA SCIENCES INC. Get notifications about new insider transactions in ALIMERA SCIENCES INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 3.56 | 500 | 1,781 | 25,630 | 25.1 K to 25.6 K (+1.99 %) |
| May 04 2021 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 3.56 | 500 | 1,781 | 60,043 | 59.5 K to 60 K (+0.84 %) |
| May 04 2021 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 3.56 | 421 | 1,499 | 19,566 | 19.1 K to 19.6 K (+2.20 %) |
| Apr 12 2021 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Sell | S | 9.62 | 45 | 433 | 19,379 | 19.4 K to 19.4 K (-0.23 %) |
| Mar 10 2021 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 7.64 | 1,164 | 8,893 | 19,145 | 20.3 K to 19.1 K (-5.73 %) |
| Mar 10 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Operating Off ... | Payment of Exercise | F | 7.42 | 1,935 | 14,348 | 25,130 | 27.1 K to 25.1 K (-7.15 %) |
| Mar 08 2021 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Payment of Exercise | F | 7.77 | 2,533 | 19,681 | 19,424 | 22 K to 19.4 K (-11.54 %) |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Option Exercise | A | 5.01 | 52,500 | 263,025 | 52,500 | |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.00 | 17,500 | 0 | 59,543 | 42 K to 59.5 K (+41.62 %) |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Option Exercise | A | 5.01 | 16,875 | 84,544 | 16,875 | |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.00 | 5,625 | 0 | 17,981 | 12.4 K to 18 K (+45.52 %) |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Option Exercise | A | 5.01 | 30,000 | 150,300 | 30,000 | |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Option Exercise | A | 5.01 | 30,000 | 150,300 | 30,000 | |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Grant | A | 0.00 | 10,000 | 0 | 21,957 | 12 K to 22 K (+83.63 %) |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Grant | A | 0.00 | 10,000 | 0 | 21,957 | 12 K to 22 K (+83.63 %) |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Option Exercise | A | 5.01 | 18,750 | 93,938 | 18,750 | |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.00 | 6,250 | 0 | 14,929 | 8.7 K to 14.9 K (+72.01 %) |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Option Exercise | A | 5.01 | 16,875 | 84,544 | 16,875 | |
| Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 5,625 | 0 | 27,065 | 21.4 K to 27.1 K (+26.24 %) |
| Nov 05 2020 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Buy | P | 4.50 | 1,316 | 5,922 | 11,957 | 10.6 K to 12 K (+12.37 %) |
| Nov 04 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Buy | P | 4.15 | 2,500 | 10,377 | 42,043 | 39.5 K to 42 K (+6.32 %) |
| Nov 03 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 3.56 | 500 | 1,781 | 21,440 | 20.9 K to 21.4 K (+2.39 %) |
| Nov 03 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 3.56 | 500 | 1,781 | 39,543 | 39 K to 39.5 K (+1.28 %) |
| Nov 03 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 3.56 | 500 | 1,781 | 39,543 | 39 K to 39.5 K (+1.28 %) |
| Aug 24 2020 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | Director | Sell | S | 6.73 | 5,000 | 33,650 | 5,578 | 10.6 K to 5.6 K (-47.27 %) |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Kong Garheng | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Kong Garheng | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Snisarenko John | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Largent James R | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Pizzo Peter J. III | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| Jun 22 2020 | ALIM | ALIMERA SCIENCES I ... | Szela Mary T | Director | Option Exercise | A | 6.70 | 3,333 | 22,331 | 3,333 | |
| May 01 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 3.61 | 167 | 603 | 20,940 | 20.8 K to 20.9 K (+0.80 %) |
| May 01 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 3.61 | 167 | 603 | 39,043 | 38.9 K to 39 K (+0.43 %) |
| May 01 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 3.61 | 167 | 603 | 11,935 | 11.8 K to 11.9 K (+1.42 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Grant | A | 0.00 | 5,389 | 0 | 10,641 | 5.3 K to 10.6 K (+102.61 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.00 | 3,958 | 0 | 11,768 | 7.8 K to 11.8 K (+50.68 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.00 | 3,958 | 0 | 11,768 | 7.8 K to 11.8 K (+50.68 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.00 | 10,884 | 0 | 38,876 | 28 K to 38.9 K (+38.88 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.00 | 10,884 | 0 | 38,876 | 28 K to 38.9 K (+38.88 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 5,172 | 0 | 20,773 | 15.6 K to 20.8 K (+33.15 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 5,172 | 0 | 20,773 | 15.6 K to 20.8 K (+33.15 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.00 | 4,683 | 0 | 8,679 | 4 K to 8.7 K (+117.19 %) |
| Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.00 | 4,683 | 0 | 8,679 | 4 K to 8.7 K (+117.19 %) |
| Mar 11 2020 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Payment of Exercise | F | 5.63 | 838 | 4,717 | 3,996 | 4.8 K to 4 K (-17.34 %) |
| Mar 11 2020 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Payment of Exercise | F | 6.13 | 838 | 5,137 | 4,834 | 5.7 K to 4.8 K (-14.77 %) |
| Mar 09 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Payment of Exercise | F | 6.67 | 1,958 | 13,060 | 27,992 | 30 K to 28 K (-6.54 %) |
| Mar 09 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Payment of Exercise | F | 6.37 | 1,958 | 12,472 | 29,950 | 31.9 K to 30 K (-6.14 %) |
| Mar 05 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 6.14 | 1,270 | 7,798 | 15,601 | 16.9 K to 15.6 K (-7.53 %) |
| Mar 05 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 6.85 | 1,270 | 8,700 | 16,871 | 18.1 K to 16.9 K (-7.00 %) |
| Mar 03 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 6.15 | 938 | 5,769 | 7,810 | 8.7 K to 7.8 K (-10.72 %) |
| Mar 03 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 7.05 | 938 | 6,613 | 8,748 | 9.7 K to 8.7 K (-9.68 %) |
| Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Option Exercise | A | 6.75 | 19,000 | 128,250 | 19,000 | |
| Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Option Exercise | A | 6.75 | 19,000 | 128,250 | 19,000 | |
| Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Option Exercise | A | 6.75 | 14,000 | 94,500 | 14,000 | |
| Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Option Exercise | A | 6.75 | 17,500 | 118,125 | 17,500 | |
| Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Option Exercise | A | 6.75 | 20,000 | 135,000 | 20,000 | |
| Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Option Exercise | A | 6.75 | 53,500 | 361,125 | 53,500 | |
| Jan 02 2020 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 7.58 | 78 | 591 | 9,686 | 9.6 K to 9.7 K (+0.81 %) |
| Jan 02 2020 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 7.58 | 202 | 1,531 | 31,908 | 31.7 K to 31.9 K (+0.64 %) |
| Jan 02 2020 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 7.58 | 93 | 705 | 5,672 | 5.6 K to 5.7 K (+1.67 %) |
| Jan 02 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 7.58 | 106 | 803 | 18,141 | 18 K to 18.1 K (+0.59 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 8.24 | 72 | 593 | 9,608 | 9.5 K to 9.6 K (+0.76 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 8.24 | 72 | 593 | 9,608 | 9.5 K to 9.6 K (+0.76 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 8.24 | 72 | 593 | 9,608 | 9.5 K to 9.6 K (+0.76 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 8.24 | 98 | 808 | 18,035 | 17.9 K to 18 K (+0.55 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 8.24 | 98 | 808 | 18,035 | 17.9 K to 18 K (+0.55 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 8.24 | 98 | 808 | 18,035 | 17.9 K to 18 K (+0.55 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 8.24 | 86 | 709 | 5,579 | 5.5 K to 5.6 K (+1.57 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 8.24 | 86 | 709 | 5,579 | 5.5 K to 5.6 K (+1.57 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 8.24 | 86 | 709 | 5,579 | 5.5 K to 5.6 K (+1.57 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 8.24 | 186 | 1,533 | 31,706 | 31.5 K to 31.7 K (+0.59 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 8.24 | 186 | 1,533 | 31,706 | 31.5 K to 31.7 K (+0.59 %) |
| Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 8.24 | 186 | 1,533 | 31,706 | 31.5 K to 31.7 K (+0.59 %) |
| Dec 11 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Buy | P | 9.29 | 1,000 | 9,294 | 9,536 | 8.5 K to 9.5 K (+11.72 %) |
| Dec 02 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 5.66 | 271 | 1,534 | 31,520 | 31.2 K to 31.5 K (+0.87 %) |
| Dec 02 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 5.66 | 142 | 804 | 17,937 | 17.8 K to 17.9 K (+0.80 %) |
| Dec 02 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 5.66 | 126 | 713 | 5,493 | 5.4 K to 5.5 K (+2.35 %) |
| Dec 02 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 5.66 | 105 | 594 | 8,536 | 8.4 K to 8.5 K (+1.25 %) |
| Nov 25 2019 | ALIM | ALIMERA SCIENCES I ... | Snisarenko John | Director | Buy | P | 4.95 | 10,000 | 49,500 | 10,000 | 0 to 10 K |
| Nov 20 2019 | ALIM | ALIMERA SCIENCES I ... | Largent James R | Director | Buy | P | 5.11 | 3,000 | 15,344 | 3,000 | 0 to 3 K |
| Nov 19 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 4.75 | 149 | 708 | 5,367 | 5.2 K to 5.4 K (+2.86 %) |
| Nov 19 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 4.75 | 125 | 594 | 8,431 | 8.3 K to 8.4 K (+1.50 %) |
| Nov 19 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 4.75 | 323 | 1,534 | 31,249 | 30.9 K to 31.2 K (+1.04 %) |
| Nov 14 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.30 | 25,000 | 7,473 | 463,901 | 438.9 K to 463.9 K (+5.70 %) |
| Nov 14 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.30 | 75,000 | 22,418 | 438,901 | 363.9 K to 438.9 K (+20.61 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.28 | 2,513 | 712 | 78,277 | 75.8 K to 78.3 K (+3.32 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.30 | 10,000 | 3,008 | 124,590 | 114.6 K to 124.6 K (+8.73 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.24 | 2,500 | 602 | 114,590 | 112.1 K to 114.6 K (+2.23 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.28 | 2,104 | 596 | 112,090 | 110 K to 112.1 K (+1.91 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.24 | 2,500 | 602 | 264,379 | 261.9 K to 264.4 K (+0.95 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.28 | 2,850 | 808 | 261,879 | 259 K to 261.9 K (+1.10 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.24 | 2,500 | 602 | 363,901 | 361.4 K to 363.9 K (+0.69 %) |
| Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.28 | 5,419 | 1,536 | 361,401 | 356 K to 361.4 K (+1.52 %) |
| Oct 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.40 | 2,020 | 808 | 259,029 | 257 K to 259 K (+0.79 %) |
| Oct 16 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.40 | 1,490 | 596 | 109,986 | 108.5 K to 110 K (+1.37 %) |
| Oct 16 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.40 | 3,839 | 1,536 | 355,982 | 352.1 K to 356 K (+1.09 %) |
| Oct 16 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.40 | 1,779 | 712 | 75,764 | 74 K to 75.8 K (+2.40 %) |
| Oct 02 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.57 | 1,046 | 596 | 108,496 | 107.5 K to 108.5 K (+0.97 %) |
| Oct 02 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.57 | 1,046 | 596 | 108,496 | 107.5 K to 108.5 K (+0.97 %) |
| Oct 02 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.57 | 1,417 | 808 | 257,009 | 255.6 K to 257 K (+0.55 %) |
| Oct 02 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.57 | 1,249 | 712 | 73,985 | 72.7 K to 74 K (+1.72 %) |
| Oct 02 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.57 | 2,694 | 1,536 | 352,143 | 349.4 K to 352.1 K (+0.77 %) |
| Sep 17 2019 | ALIM | ALIMERA SCIENCES I ... | Kaba Samer | Chief Medical Offic ... | Grant | A | 0.41 | 1,736 | 712 | 72,736 | 71 K to 72.7 K (+2.45 %) |
| Sep 17 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.41 | 1,970 | 808 | 255,592 | 253.6 K to 255.6 K (+0.78 %) |
| Sep 17 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.41 | 3,745 | 1,535 | 349,449 | 345.7 K to 349.4 K (+1.08 %) |
| Sep 17 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.41 | 1,454 | 596 | 107,450 | 106 K to 107.5 K (+1.37 %) |
| Jul 22 2019 | ALIM | ALIMERA SCIENCES I ... | Snisarenko John | Director | Option Exercise | A | 0.87 | 46,150 | 39,920 | 46,150 | |
| Jul 22 2019 | ALIM | ALIMERA SCIENCES I ... | Snisarenko John | Director | Option Exercise | A | 0.87 | 46,150 | 39,920 | 46,150 | |
| Jun 21 2019 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| Jun 20 2019 | ALIM | ALIMERA SCIENCES I ... | Kong Garheng | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| Jun 20 2019 | ALIM | ALIMERA SCIENCES I ... | Pizzo Peter J. III | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| Jun 20 2019 | ALIM | ALIMERA SCIENCES I ... | Largent James R | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| Jun 20 2019 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| Jun 20 2019 | ALIM | ALIMERA SCIENCES I ... | Szela Mary T | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| May 01 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.82 | 2,500 | 2,061 | 345,704 | 343.2 K to 345.7 K (+0.73 %) |
| May 01 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.82 | 1,633 | 1,346 | 110,229 | 108.6 K to 110.2 K (+1.50 %) |
| Feb 08 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Payment of Exercise | F | 0.96 | 14,833 | 14,240 | 142,104 | 156.9 K to 142.1 K (-9.45 %) |
| Feb 08 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Payment of Exercise | F | 0.95 | 14,833 | 14,105 | 156,937 | 171.8 K to 156.9 K (-8.64 %) |
| Feb 06 2019 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | Director | Payment of Exercise | F | 0.98 | 21,966 | 21,472 | 158,676 | 180.6 K to 158.7 K (-12.16 %) |
| Feb 06 2019 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | Director | Payment of Exercise | F | 0.94 | 21,966 | 20,648 | 180,642 | 202.6 K to 180.6 K (-10.84 %) |
| Feb 05 2019 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | Chief Scientific Of ... | Payment of Exercise | F | 0.93 | 10,815 | 10,099 | 210,104 | 220.9 K to 210.1 K (-4.90 %) |
| Feb 05 2019 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | Chief Scientific Of ... | Payment of Exercise | F | 0.85 | 10,815 | 9,194 | 220,919 | 231.7 K to 220.9 K (-4.67 %) |
| Jan 31 2019 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Payment of Exercise | F | 0.84 | 13,254 | 11,137 | 29,892 | 43.1 K to 29.9 K (-30.72 %) |
| Jan 31 2019 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Payment of Exercise | F | 0.82 | 13,254 | 10,913 | 43,146 | 56.4 K to 43.1 K (-23.50 %) |
| Jan 31 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 0.84 | 9,983 | 8,389 | 146,022 | 156 K to 146 K (-6.40 %) |
| Jan 31 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 0.82 | 9,983 | 8,220 | 156,005 | 166 K to 156 K (-6.01 %) |
| Jan 28 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 0.85 | 1,411 | 1,197 | 24,963 | 26.4 K to 25 K (-5.35 %) |
| Jan 28 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 0.86 | 1,411 | 1,218 | 26,374 | 27.8 K to 26.4 K (-5.08 %) |
| Jan 28 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 0.83 | 1,411 | 1,172 | 27,785 | 29.2 K to 27.8 K (-4.83 %) |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Option Exercise | A | 0.86 | 250,000 | 215,000 | 250,000 | |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Grant | A | 0.00 | 79,400 | 0 | 108,596 | 29.2 K to 108.6 K (+271.96 %) |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Option Exercise | A | 0.86 | 170,000 | 146,200 | 170,000 | |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 107,600 | 0 | 247,600 | 140 K to 247.6 K (+76.86 %) |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Option Exercise | A | 0.86 | 500,000 | 430,000 | 500,000 | |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CEO | Grant | A | 0.00 | 201,100 | 0 | 372,870 | 171.8 K to 372.9 K (+117.08 %) |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Option Exercise | A | 0.86 | 200,000 | 172,000 | 200,000 | |
| Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | Chief Operating Off ... | Grant | A | 0.00 | 92,300 | 0 | 148,700 | 56.4 K to 148.7 K (+163.65 %) |
| Jan 24 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 0.83 | 1,411 | 1,171 | 29,196 | 30.6 K to 29.2 K (-4.61 %) |
| Jan 24 2019 | ALIM | ALIMERA SCIENCES I ... | Jones John Philip | Chief Financial Off ... | Payment of Exercise | F | 0.83 | 1,411 | 1,167 | 30,607 | 32 K to 30.6 K (-4.41 %) |
| Jun 21 2018 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| Jun 21 2018 | ALIM | ALIMERA SCIENCES I ... | Szela Mary T | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| Jun 20 2018 | ALIM | ALIMERA SCIENCES I ... | Brooks Mark J | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| Jun 20 2018 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| Jun 20 2018 | ALIM | ALIMERA SCIENCES I ... | Pizzo Peter J. III | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| Jun 20 2018 | ALIM | ALIMERA SCIENCES I ... | Largent James R | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| Jun 20 2018 | ALIM | ALIMERA SCIENCES I ... | Kong Garheng | Director | Option Exercise | A | 0.86 | 40,000 | 34,400 | 40,000 | |
| May 07 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Buy | P | 1.05 | 10,000 | 10,500 | 171,770 | 161.8 K to 171.8 K (+6.18 %) |
| Feb 09 2018 | ALIM | ALIMERA SCIENCES I ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.12 | 8,000 | 8,960 | 6,936,000 | 6.9 M to 6.9 M (+0.12 %) |